Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact
Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact

Developing new imaging approach for methionine aminopeptidase II for prostate cancer risk stratification

February 1, 2021

Exciting new results from our lab collaborative work reveal a new imaging approach for risk stratification of prostate cancer.

https://cancerres.aacrjournals.org/content/81/9/2510

February 1, 2021

NewsStanford

FacebookXPinterestRedditDeliciousWhatsappEmail
  • PreviousDr. Demirci and Dr. Stoyanova receive Spectrum MedTech Pilot Grant

  • NextNew review article on the role of Trop2 in prostate cancer

Related Posts ...

Exciting News: Francisco Solano is now a PhD candidate

News

Excited to Share Our New Publication: CDC7 is a targetable regulator of advanced prostate cancer

News

Logo

ADDRESS

Los Angeles
CA 90095, USA
tstoyanova@mednet.ucla.edu

+1 (310) 825 0955

QUICK LINKS

  • UCLA
  • UCLA Health
  • Positions Available
© Stoyanova Lab. All Rights Reserved. | admin login